» Authors » J Oscar Croxatto

J Oscar Croxatto

Explore the profile of J Oscar Croxatto including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 215
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gentile C, Muller Y, Tajtelbaum L, Lombardi A, Croxatto J
Medicina (B Aires) . 2024 Oct; 84(5):902-912. PMID: 39399930
Introduction: Primary uveal melanoma is the most common intraocular malignancy in adults. Almost 50% of patients die from metastatic disease despite successful local treatment. The objective was to estimate the...
2.
Perez V, Sampor C, Rey G, Parareda-Salles A, Kopp K, Dabezies A, et al.
JAMA Ophthalmol . 2018 May; 136(7):747-752. PMID: 29799944
Importance: Multi-institutional collaborative studies that include large patient populations for the management of retinoblastoma with histopathological risk factors could provide important information for patient management. Objective: To evaluate the implementation...
3.
Mancini J, Ortiz G, Potilinstki C, Salica J, Lopez E, Croxatto J, et al.
Diabetol Metab Syndr . 2018 Apr; 10:31. PMID: 29682007
Background: Purinergic receptors are expressed in different tissues including the retina. These receptors are involved in processes like cell growth, proliferation, activation and survival. ATP is the major activator of...
4.
Lopez E, Ortiz G, Potilinski C, Croxatto J, Gallo J
Curr Eye Res . 2017 Dec; 43(4):466-473. PMID: 29265937
Purpose: The objective is to analyze the antiangiogenic mechanism of suramab, a pharmaceutical compound of bevacizumab and suramin, in a rabbit model of corneal angiogenesis. Material And Methods: Corneal neovascularization...
5.
Francis J, Schaiquevich P, Buitrago E, Del Sole M, Zapata G, Croxatto J, et al.
Ophthalmology . 2014 May; 121(9):1810-7. PMID: 24819859
Purpose: Intravitreal melphalan is emerging as an effective treatment for refractory vitreous seeds in retinoblastoma, but there is limited understanding regarding its toxicity. This study evaluates the retinal and systemic...
6.
Belforte N, Sande P, Dorfman D, Croxatto J, Rosenstein R
Retina . 2011 Jun; 31(10):2115-22. PMID: 21642899
Background: Radial optic neurotomy (RON) has been proposed as a treatment for central retinal vein occlusion. However, it is still under debate whether RON would be an adequate treatment or...
7.
Bernardini F, Croxatto J, Bandelloni R
Ophthalmology . 2011 Feb; 118(6):1189-92. PMID: 21276618
Purpose: To report a unique case of primary undifferentiated large cell carcinoma (LCCA) of the lacrimal gland, a tumor not previously described in the ophthalmic literature. Design: Single interventional case...
8.
Lopez E, Rizzo M, Croxatto J, Mazzolini G, Gallo J
Cancer Chemother Pharmacol . 2010 Sep; 67(3):723-8. PMID: 20857116
Purpose: Oncological and ophthalmological diseases are increasingly treated with antiangiogenic agents. These agents have different intensities and duration of effects that should be considered to choose the most suitable therapy....
9.
Luengo Gimeno F, Lavigne V, Gatto S, Croxatto J, Correa L, Gallo J
Mol Vis . 2009 Dec; 15:2771-9. PMID: 20019875
Purpose: To evaluate the usefulness of epithelial corneal sheets mounted on platelet poor plasma (PPP) for allograft transplantation of rabbits with total limbal stem cell deficiency (LSCD) and to prove...
10.
Croxatto J, Tytiun A, Argento C
J Refract Surg . 2009 Nov; 26(9):638-45. PMID: 19928694
Purpose: To evaluate the short- and long-term sequential histological changes of the cornea in vivo after corneal collagen cross-linking (CXL) in patients with keratoconus. Methods: Eighteen patients with keratoconus (Amsler-Krumeich...